ShervinAssassiMD

Rheumatology • Houston, TX

Professor & Director, Division of Rheumatology, University of Texas Health Science Center at Houston

Join to view full profile

Dr. Assassi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Assassi's full profile

Already have an account?

Office
6431 Fannin St
Msb 5.270
Houston, TX 77030
Phone+1 713-500-6900

Fax+1 713-500-0580

Education & Training

University of Texas Health Science Center at HoustonFellowship, Rheumatology, 2003 - 2005
University of Texas Health Science Center at HoustonResidency, Internal Medicine, 2000 - 2003
Albert Ludwigs University Faculty of MedicineClass of 1999

Certifications & Licensure

TX State Medical License 2005 - 2025

Awards, Honors, & Recognition

Super Doctor SuperDoctors.com
Fellow (FACR) American College of Rheumatology

Publications & Presentations

PubMed

Addressing statistical challenges in the analysis of proteomics data with extremely small sample size: a simulation study.
Kyung Hyun Lee, Shervin Assassi, Chandra Mohan, Claudia Pedroza
BMC Genomics. 2024-11-14
Design of CONQUEST, a novel, randomized, placebo-controlled, Phase 2b platform clinical trial to investigate new treatments for patients with early active systemic scl...
Dinesh Khanna, Luke B Evnin, Shervin Assassi, Wade W Benton, Gregory Gordon
Journal of Scleroderma and Related Disorders. 2024-11-05
FAM13A polymorphism is associated with a usual interstitial pneumonia pattern in patients with systemic sclerosis-associated interstitial lung disease.
Elana J Bernstein, Francesco Boin, Brett Elicker, Yiming Luo, Yawen Ren
Rheumatology. 2024-10-17

Journal Articles

The Scleroderma Patient-Centered Intervention Network Cohort: Baseline Clinical Features and Comparison with Other Large Scleroderma Cohorts
Daniel E Furst, Robert Spiera, Maureen D Mayes, Lorinda Chung, Suzanne Kafaja, Virginia Steen, Shervin Assassi, Monique Hinchcliff, Rheumatology

Press Mentions

Durable Efficacy for Drug Preventing Lung Progression in Systemic SclerosisJuly 20th, 2022
Higher Cardiovascular Risks in Kawasaki Disease Persist 10-plus YearsNovember 8th, 2020
Dr. Shervin Assassi: New Chair of the ACR Committee on Journal PublicationsApril 18th, 2019
Join now to see all

Professional Memberships

American College of Rheumatology - ACR
Fellow